Skip to content

Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

Battlefield Acupuncture to Treat Pain in Hidradenitis Suppurativa

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04218422
Enrollment
32
Registered
2020-01-06
Start date
2020-01-22
Completion date
2031-02-20
Last updated
2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hidradenitis Suppurativa

Keywords

acupuncture, pain, battlefield acupuncture, hidradenitis

Brief summary

The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.

Detailed description

Participants will report their pain level daily for 4 weeks. At week 2 and 3, they will get acupuncture in the ears.

Interventions

Acupuncture at 5 points on the ears

PROCEDURESham Acupuncture

Sham acupuncture in 2 points for liver and 1 point for stomach

Sponsors

Wayne State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Participants will not know whether they got battlefield acupuncture or sham acupuncture

Intervention model description

Blinded, randomized trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age 18 years or older * dermatologist-confirmed diagnosis of hidradenitis suppurativa * significant pain from hidradenitis at least twice weekly * stable treatment regimen for hidradenitis during study period

Exclusion criteria

* disease or disfigurement of the ear that prevents battlefield acupuncture of the ears * other chronic pain that will interfere with the ability to rate hidradenitis pain

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain Numerical Rating ScoreAverage Score from scores Recorded daily for 4 weeksDifference in Average Patient self-reported Pain Numerical Rating Score from 0-10, comparing average from 2 weeks prior to treatment with average from 2 weeks after treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026